Showing results (351-360 of 587) with videos related to
Sort By:
Pageof 59
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterationsMariona Riudavets, Edouard Auclin, Miguel Mosteiro, et al.JTO Clinical and Research Reports|May 20, 2022
Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLCBruce E Johnson, Christina S Baik, Julien Mazieres, et al.The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.European Journal of Cancer (Oxford, England : 1990)|November 20, 2022
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscleSami Antoun, Emilie Lanoy, Samy Ammari, et al.Frontiers in Oncology|February 7, 2024
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus reportMyriam Mirza, Aseem Shrivastava, Cecile Matthews, et al.Lung Cancer (Amsterdam, Netherlands)|January 10, 2024
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastasesSolange Peters, José Trigo, Benjamin Besse, et al.Clinical Lung Cancer|May 12, 2026
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLCMarina Chiara Garassino, Sophie Cousin, Benjamin Besse, et al.BMC Cancer|July 16, 2016
Method for semi-automated microscopy of filtration-enriched circulating tumor cellsEmma Pailler, Marianne Oulhen, Fanny Billiot, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancerGiorgio V Scagliotti, Enriqueta Felip, Benjamin Besse, et al.Lung Cancer (Amsterdam, Netherlands)|July 14, 2005
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancerRafael Rosell, Yukito Ichinose, Miquel Taron, et al.Pageof 59